Moreover, LCP1 has been linked to immune cell infiltration and inflammatory signaling in various cancers, including triple-negative breast cancer [21], and ischemic brain injury, where it modulates macrophage function and cytokine production [58]. Here, LCP1 is linked to triple-negative breast carcinoma.